Techniques developed in China for foot-and-mouth disease diagnosis

Transbound Emerg Dis. 2008 Aug;55(5-6):196-9. doi: 10.1111/j.1865-1682.2008.01027.x.

Abstract

Over the past several decades, a series of new methods have been developed in China for the diagnosis of foot-and-mouth disease (FMD). These methods are theoretically consistent with Office International des Epizooties standards for FMD diagnosis and include: antigen-capture ELISA and colloid-gold test strip for viral antigen typing, liquid-phase blocking ELISA (LPBE) for detection of antibodies against O and Asia 1 FMDV, and an indirect ELISA for detection of antibodies against the non-structural protein (NSP) 3ABC (3ABC-I-ELISA). Several molecular diagnostic methods have also been developed for detection of fragments of the FMDV genome within viral samples, such as multiplex RT-PCR, typing RT-PCR and real-time RT-PCR. In China, FMD vaccines are compulsorily used in all livestock. In such a situation, monitoring of the immune status of animal herds and disease surveillance become very important. Liquid-phase blocking ELISA is routinely used in China for monitoring the immune status, and 3ABC-I-ELISA is feasible for large-scale serological surveys based on differentiation of FMDV-infected animals from vaccinated animals. Combined use of 3ABC-ELISA and mRT-PCR is described for survey of FMD virus-prevalent herds and virus carriers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrier State / veterinary
  • China
  • Clinical Laboratory Techniques / standards
  • Clinical Laboratory Techniques / veterinary*
  • Enzyme-Linked Immunosorbent Assay / methods
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Foot-and-Mouth Disease / diagnosis*
  • Foot-and-Mouth Disease / prevention & control
  • Foot-and-Mouth Disease Virus / isolation & purification*
  • Polymerase Chain Reaction / methods
  • Polymerase Chain Reaction / veterinary
  • Sentinel Surveillance / veterinary
  • Viral Vaccines / administration & dosage*

Substances

  • Viral Vaccines